Welcome to our dedicated page for ECOLAB SEC filings (Ticker: ECL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ecolab Inc. filings document the public-company disclosures of a Delaware operating company whose common stock trades on the New York Stock Exchange under ECL. The filings cover operating and financial results, supplemental segment reporting, changes to reportable segment structure, capital-structure information and material-event reports.
Proxy and 8-K filings describe annual-meeting matters, board and executive-leadership changes, compensation and governance topics, and shareholder voting materials. Other disclosures address material agreements, restructuring and exit-cost matters associated with the One Ecolab initiative, business context for water, hygiene and infection prevention operations, and the company’s service footprint across multiple customer industries.
ECL: A holder filed a Form 144 notice to sell up to 21,714 shares of common stock, with an aggregate market value of $5,690,154, on or about 11/12/2025. The planned broker is Morgan Stanley Smith Barney LLC – Executive Services, and the shares are listed on the NYSE.
The filing also discloses an acquisition of 23,071 shares on 11/12/2025 via a stock option exercise using a broker-assisted cashless exercise. This Form 144 is a notice of proposed sale under Rule 144 and does not itself execute the transaction.
Ecolab Inc. reported Q3 2025 results. Net sales were $4,165.0 million, up from $3,998.5 million. Operating income was $760.2 million versus $1,044.8 million a year ago, as the prior period included sizable gains while Q3 2025 recorded total special (gains) and charges of $26.5 million. Diluted EPS was $2.05 compared with $2.58. Net income attributable to Ecolab was $585.0 million versus $736.5 million.
For the first nine months, net sales were $11,885.2 million and diluted EPS was $5.30. Cash from operations reached $1,862.5 million, ending cash was $1,955.8 million, and long‑term debt was $8,052.7 million. The company issued $500 million three‑year notes at 4.30% and $500 million ten‑year notes at 5.00%, and repaid €575 million of 2015 notes.
Ecolab expanded its One Ecolab initiative, anticipating restructuring costs of $240 million and special charges of $60 million by the end of 2027; cumulative restructuring charges recorded total $148.1 million with cumulative special charges of $48.3 million. The company agreed to acquire Ovivo Electronics for $1.8 billion (CAD 2.4B) and entered foreign currency options totaling CAD 2.2B. Shares outstanding were 283,235,653 as of September 30, 2025.
Ecolab Inc. reported that it announced earnings for the third quarter ended September 30, 2025, via a Form 8-K under Item 2.02. The company furnished a News Release as Exhibit 99.1 and Supplemental Data as Exhibit 99.2, and noted these materials will also be available on its website.
The exhibits are furnished, not filed, under the Exchange Act. Ecolab’s common stock (par value $1.00) trades on the New York Stock Exchange under the symbol ECL.
John J. Zillmer, a director of Ecolab Inc. (ECL), reported acquiring 123.23 shares of Ecolab common stock on 09/30/2025 at a reported price of $0. After the transaction his beneficial ownership is reported as 47,425.86 shares. The filing notes that 38.02 of the shares were acquired through a dividend reinvestment feature of the company’s 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. The Form 4 was signed by an attorney-in-fact on 10/02/2025. The filing documents an insider acquisition and provides the exact change in a director’s reported holdings without additional commentary or valuation context.
Victoria J. Reich, a director of Ecolab Inc. (ECL), reported an acquisition of 123.23 shares of Ecolab common stock on 09/30/2025. The transaction is listed as an acquisition with a reported price of $0, and the filing explains that 57.70 of the shares were received through a dividend reinvestment feature of the company’s 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. After the transaction, Ms. Reich is reported to beneficially own 24,991.11 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 10/02/2025.
Lionel L. Nowell III, a director of Ecolab Inc. (ECL), reported a transaction dated 09/30/2025 on a Form 4. The filing shows an acquisition of 123.23 shares of Ecolab common stock at a reported price of $0, and total beneficial ownership following the reported transaction of 6,328.16 shares. The filing discloses that 14.79 of those shares were acquired through a dividend reinvestment feature of the company’s Non-Employee Director Stock Option and Deferred Compensation Plan. The document is signed by an attorney-in-fact on behalf of Mr. Nowell on 10/02/2025.
David W. MacLennan, a director of Ecolab Inc. (ECL), reported purchases of company common stock on 09/30/2025. He directly acquired 123.23 shares at $0 (received via a plan) and 42.22 shares at $273.87, bringing his direct ownership to 20,436.08 shares. The filing also discloses 3,500 shares held indirectly by the Kathleen F. MacLennan Revocable Trust and 709 shares held indirectly by sibling trusts. The report notes that 17.14 of the acquired shares were from a dividend reinvestment feature of the company’s 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. The Form 4 was signed by an attorney-in-fact on behalf of Mr. MacLennan on 10/02/2025.
Michael Larson, a director of Ecolab Inc. (ECL), reported a transaction dated 09/30/2025 on Form 4 showing an acquisition of 123.23 shares of Ecolab common stock at a reported price of $0. The filing states the position after the transaction was 17,396.17 shares beneficially owned. An explanatory note clarifies that 24.57 of the shares were acquired through a dividend reinvestment feature of the company’s 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. The form is signed by an attorney-in-fact on behalf of Mr. Larson with a signature date of 10/02/2025.
Ecolab director Marion K. Gross reported a purchase of 123.23 shares of Ecolab common stock on 09/30/2025, increasing her beneficial ownership to 199.49 shares. The transaction is reported on a Form 4 signed by an attorney-in-fact on 10/02/2025. The filing shows the acquisition as a non-derivative transaction (code V) with a reported price of $0 on the line item; the form lists ownership as Direct (D). No additional explanatory text or material context is provided in the filing.
Eric M. Green, a director of Ecolab Inc. (ECL), reported two acquisitions of Ecolab common stock on 09/30/2025. The Form 4 shows an acquisition of 123.23 shares with a reported price of $0 and a separate acquisition of 132.37 shares with a reported price of $273.87, leaving total beneficial ownership of 3,401.71 shares after the transactions. The filing discloses that 7.02 of the shares were acquired through a dividend reinvestment feature of the company's Non-Employee Director Stock Option and Deferred Compensation Plan. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Green on 10/02/2025.